Cargando…

Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies

A long scientific journey has led to prominent technological advances in the RNA field, and several new types of molecules have been discovered, from non-coding RNAs (ncRNAs) to riboswitches, small interfering RNAs (siRNAs) and CRISPR systems. Such findings, together with the recognition of the adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Costa, Vanessa G., Costa, Susana M., Saramago, Margarida, Cunha, Marta V., Arraiano, Cecília M., Viegas, Sandra C., Matos, Rute G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697208/
https://www.ncbi.nlm.nih.gov/pubmed/36422373
http://dx.doi.org/10.3390/microorganisms10112303
_version_ 1784838503548321792
author Costa, Vanessa G.
Costa, Susana M.
Saramago, Margarida
Cunha, Marta V.
Arraiano, Cecília M.
Viegas, Sandra C.
Matos, Rute G.
author_facet Costa, Vanessa G.
Costa, Susana M.
Saramago, Margarida
Cunha, Marta V.
Arraiano, Cecília M.
Viegas, Sandra C.
Matos, Rute G.
author_sort Costa, Vanessa G.
collection PubMed
description A long scientific journey has led to prominent technological advances in the RNA field, and several new types of molecules have been discovered, from non-coding RNAs (ncRNAs) to riboswitches, small interfering RNAs (siRNAs) and CRISPR systems. Such findings, together with the recognition of the advantages of RNA in terms of its functional performance, have attracted the attention of synthetic biologists to create potent RNA-based tools for biotechnological and medical applications. In this review, we have gathered the knowledge on the connection between RNA metabolism and pathogenesis in Gram-positive and Gram-negative bacteria. We further discuss how RNA techniques have contributed to the building of this knowledge and the development of new tools in synthetic biology for the diagnosis and treatment of diseases caused by pathogenic microorganisms. Infectious diseases are still a world-leading cause of death and morbidity, and RNA-based therapeutics have arisen as an alternative way to achieve success. There are still obstacles to overcome in its application, but much progress has been made in a fast and effective manner, paving the way for the solid establishment of RNA-based therapies in the future.
format Online
Article
Text
id pubmed-9697208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96972082022-11-26 Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies Costa, Vanessa G. Costa, Susana M. Saramago, Margarida Cunha, Marta V. Arraiano, Cecília M. Viegas, Sandra C. Matos, Rute G. Microorganisms Review A long scientific journey has led to prominent technological advances in the RNA field, and several new types of molecules have been discovered, from non-coding RNAs (ncRNAs) to riboswitches, small interfering RNAs (siRNAs) and CRISPR systems. Such findings, together with the recognition of the advantages of RNA in terms of its functional performance, have attracted the attention of synthetic biologists to create potent RNA-based tools for biotechnological and medical applications. In this review, we have gathered the knowledge on the connection between RNA metabolism and pathogenesis in Gram-positive and Gram-negative bacteria. We further discuss how RNA techniques have contributed to the building of this knowledge and the development of new tools in synthetic biology for the diagnosis and treatment of diseases caused by pathogenic microorganisms. Infectious diseases are still a world-leading cause of death and morbidity, and RNA-based therapeutics have arisen as an alternative way to achieve success. There are still obstacles to overcome in its application, but much progress has been made in a fast and effective manner, paving the way for the solid establishment of RNA-based therapies in the future. MDPI 2022-11-21 /pmc/articles/PMC9697208/ /pubmed/36422373 http://dx.doi.org/10.3390/microorganisms10112303 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Costa, Vanessa G.
Costa, Susana M.
Saramago, Margarida
Cunha, Marta V.
Arraiano, Cecília M.
Viegas, Sandra C.
Matos, Rute G.
Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
title Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
title_full Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
title_fullStr Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
title_full_unstemmed Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
title_short Developing New Tools to Fight Human Pathogens: A Journey through the Advances in RNA Technologies
title_sort developing new tools to fight human pathogens: a journey through the advances in rna technologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697208/
https://www.ncbi.nlm.nih.gov/pubmed/36422373
http://dx.doi.org/10.3390/microorganisms10112303
work_keys_str_mv AT costavanessag developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies
AT costasusanam developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies
AT saramagomargarida developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies
AT cunhamartav developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies
AT arraianoceciliam developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies
AT viegassandrac developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies
AT matosruteg developingnewtoolstofighthumanpathogensajourneythroughtheadvancesinrnatechnologies